Cordlife Group
Cordlife Group Limited founded in 2001, is a leading company dedicated to safeguarding the well-being of mother and child.
Cordlife retains Chen Xiaoling on board after arrest
Chen will oversee the internal investigation into company lapses in Singapore.
1 day ago
Cordlife retains Chen Xiaoling on board after arrest
Chen will oversee the internal investigation into company lapses in Singapore.
1 day ago
Cordlife cancels $8.2m private placement
The Ministry of Health also wrote to the company regarding its local directors.
Cordlife clients receive refund offer for storage incident
The private blood bank has offered affected clients with free storage.
Cordlife hit with demand letter over alleged negligence
The client's claim is between $60,000 and $250,000.
Cordlife announces KPMG's exit following FY2023 report
KPMG's retirement follows their "Disclaimer of Opinion" on the group's FY2023 financial statements.
Cordlife directors seek court block on share issue
The company earlier announced the issuance of 51.2 million shares via private placement.
Cordlife Group aims to raise $8.04m in private placement
It issued 51.2 million new shares at $0.16 apiece.
Cordlife seeks extension for AGM, sustainability report deadlines due to 2023 earnings delay
The company is requesting for a two-week extension.
MOH finds 5,300 more ‘non-viable’ cord blood units at Cordlife
One tank experienced a temperature excursion due to delayed replenishment of liquid nitrogen.
Cordlife extends trading halt for third time
The company has yet to resume trading since April 1.
Cordlife tackles all but one of TransGlobal's proposed resolution
The company said “Shally Chen” was not listed as its director.
Cordlife halts trading pending announcement
The trading halt took immediate effect.
Cordlife Group Limited approves potential acquisition by NJXJK
NJXJK is currently reviewing its stake at Cordlife Group with SAC Capital.
MOH sets deadline for Cordlife to comply with regulations
Cordlife has not been allowed to collect, store, or process new cord blood since 30 Nov.
Commentary
Singapore Companies Eye Vietnam to Navigate Manufacturing Shifts, Green Transition, and the AI Revolution